Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03029780
Title An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

renal cell carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Specialists of North FL Jacksonville Florida 32256 United States Details
University Of Iowa Hospitals And Clinics Iowa City Iowa 52242 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Local Institution Pittsburgh Pennsylvania 15212-0000 United States Details
Local Institution Waratah New South Wales 2298 Australia Details
Local Institution Westmead New South Wales 2145 Australia Details
Local Institution Herston Queensland 4029 Australia Details
Local Institution Elizabeth Vale South Australia 5112 Australia Details
Local Institution Malvern Victoria 3144 Australia Details
Fundacion Arturo Lopez Perez Santiago Metropolitana 7500921 Chile Details
Centro Internacional de Estudios Clinicos Recoleta Santiago De Chile Chile Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field